Overexpression of NRP1 in BT-747 breast cancer cells leads to upregulation of the oncogene Tenascin-C and is accompanied by an increase in cellular tumorigenic behavior and downregulated breast cancer resistance protein (BCRP/ABCG2), resulting in enhanced sensitivity to chemotherapy [56]. Here, ABCG2 is linked to breast carcinoma.